Jubilant Pharmova Ltd. (JUBILANT LIFE SCIENCES )

Company Overview

Jubilant Pharmova Ltd. is a global pharmaceutical company that operates its operations through six segments: Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, CRDMO, Generics, and Proprietary Novel Drugs.

The company caters to the skin allergy testing market through the Allergy Immunotherapy segment with the help of its subsidiary HollisterStier Allergy. The company offers bulk allergen extracts to physicians for diagnostic testing and immunotherapy. The company also provides various specialized diagnostic devices for skin testing. It exclusively manufactures and supplies venom immunotherapy products in the U.S.

The company has a strong market presence in the U.S. and is expanding into other regions beyond North America, including the European Union, the Middle East, Africa, and Asia-Pacific.

Financial Highlights (FY 2023)

Company's Business Segments

• Radiopharma : This segment includes the development, manufacturing, and commercialization of developing, manufacturing, and commercializing of products through the
• Allergy Immunotherapy : Radiopharmaceuticals business and distributions.
• Contract Development and Manufacturing Organisation (CDMO) Sterile Injectables : This segment offers preventive treatments for allergic reactions to a variety of allergens, including Pollen, Mold, PET dander, Food, and Insects (treated by venom immunotherapy).
• Generics : This segment is primarily driven by the increase in the development pipeline in biologics and the loss of exclusivity.
• Contract Research, Development and Manufacturing Organisation (CRDMO) : This business includes developing, manufacturing, distributing, selling, and marketing generic formulations.
• Proprietary Novel Drugs : This segment includes drug discovery services and CDMO-API business.